logo
Plus   Neg
Share
Email

CVS Health Initiates Clinical Trial For New Home Hemodialysis Device

CVS Health (CVS) said that it has initiated a clinical trial designed to evaluate the safety and efficacy of the HemoCare Hemodialysis System for administration of home hemodialysis. The device includes safety features and is designed to make home hemodialysis simple for patients. It represents next step in company-wide strategy to help improve kidney disease diagnosis and management.

Home hemodialysis helps facilitate longer, more frequent dialysis treatments as compared to in-center treatments.

Currently, hemodialysis, which uses a machine to clean a patient's blood, is most commonly administered in a dialysis center three times per week. However, an expanding body of scientific literature indicated that clinical outcomes for hemodialysis patients can be improved if treatments are longer in duration, which can be challenging to achieve via in-center dialysis.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Libra Association, formed by major financial partners of Facebook's Libra cryptocurrency project, formalized the association at the inaugural Libra Council meeting of the members at its headquarters in Geneva, Switzerland. The current 21 member organizations formally signed onto the Libra Association charter, elected the Board of Directors, and appointed the executive team. Department store chain Kohl's Corp. has unveiled its Kohl's Cares holiday collection that includes the Disney Frozen 2 and Holiday Character bundles. The company's philanthropic program, Kohl's Cares, sells children's books as well as toys and donates the entire profit to charitable initiatives nationwide. Children's Place Inc. (PLCE) said that it will relaunch the Gymboree brand in the U.S. and Canada in early 2020. The brand will be relaunched in Gymboree website, and in shop-in-shop locations in more than 200 Children's Place stores in the U.S. and Canada.
Follow RTT
>